Quality Outcomes 2011
For healthcare professionals, payers and employers, quality cancer care tends to be defined by clinical outcomes – particularly those that impact patient mortality, morbidity and cost of care – and to be rooted in evidence-based medicine and best practices. From a patient and family member’s perspective, however, that definition is often expanded to include measures related to individual needs and preferences.
Quality Outcomes Data by Cancer
Breast | Colorectal | Lung | Leukemia | Prostate
Quality Outcomes Data for Robotic Surgery
Bladder | Prostate
RPCI’s 122-page quality report takes a broad, balanced look at both types of measures, providing data on general and disease-site-specific trends and outcomes as well as patient quality-of-life services and programs. The report primarily uses national benchmarking data collected by the Surveillance, Epidemiology, and End Results program of the National Cancer Institute, and the National Cancer Data Base of the American Cancer Society and the American College of Surgeons Commission on Cancer.
“We at Roswell Park Cancer Institute believe that the best, most direct way of engendering confidence in our cancer patients – and the physicians, payers and employers who entrust them to our care – is by applying current best practices and continually reviewing, measuring and sharing outcomes,” said Donald L. Trump, MD, FACP, President & CEO of RPCI. “With this publication, we hope to demonstrate that our cancer care and services are driven and supported by science, are delivered safely with compassion and vision, are consistently monitored and revised for quality assurance, and are in complete alignment with our mission to understand, prevent and cure cancer.
